Stereotaxis (STXS) Reports Q4 Loss Per Share of $0.10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Stereotaxis Reports 2015 Fourth Quarter and Full Year Financial Results
February 22, 2016 4:05 PM ESTNew capital orders of $5.1 million in the fourth quarter, including two Niobe® ES system orders in JapanFourth quarter free cash flow of $1.6 million, driving a 71% reduction in full year cash burn compared to 2014Ventricular Tachycardia procedures in the fourth quarter grew 28% year over year, with increased clinical evidence supporting Stereotaxis technology as the standard of careTotal revenue for 2015 increased 8% year over year to $37.7 millionFull year systems revenue increased 36% year over year on seven Niobe® ES system sales, up from three in 2014Conference call today at 4:30 p.m. Eastern Time
ST. LOUIS, Feb.... More
